|
Publish Biotechnology Articles or Industry News
Biotech Professionals and Students - Share your knowledge - Get Recognition |
Home | Submit Articles | Login |
| ALL Categories | AGRICULTURE | CAREERS | GENETICS | HEALTHCARE | ISSUES | NEWS | STEM CELLS |
MMS Hosts 2011 Scientific SymposiumBY: Don Mclean | Category: Press Release | Submitted: 2011-09-22 09:09:36
Canton, MI (September 21, 2011) - MMS Holdings Inc. is pleased to share news of a successful 2011 Scientific Symposium. This meeting of industry professionals and researchers was held on Wednesday, August 10th, 2011 at the MMS global headquarters in Canton, Michigan. This near capacity event was open to all colleagues in the pharmaceutical and biotechnology arenas. After a brief note of welcome, Stuart Dombey, M.B., F.R.C.P., Chief Scientific and Regulatory Officer and Founder at QuatRx Pharmaceuticals, shared an insightful presentation on the "Patterns in the Regulatory Environment" followed by a presentation from Mark P. Fletcher, MD FAAAAI, Clinical Board Member titled "Biosimilars Development: The Regulatory Challenges". The final presentation and discussion was led by R. Michael Poole, MD, Chief Medical Officer at Link Medicine Corporation on the topic of "Autophagy and the Mitochondrial Life-Cycle." "We were pleased to host the symposium event again this year. The industry we work in is ever-changing and we value the opportunity to meet as a scientific and technical team to discuss novel therapy and topics that most influence the environment we work in" said Kelly J. Hill, MS CRDSA, Director of Project and Account Management at MMS Holdings Inc. "It was a great honor to have these pharmaceutical industry leaders join us for this discussion." We hope you join us next year for this great scientific gathering. To view our 2011 Scientific Symposium agenda visit www.mmsholdings.com/news.htm To view photos from the event visit our Facebook at www.facebook.com/mmsholdings About MMS Holdings Inc. MMS Holdings Inc. is based in Canton, MI and is a highly experienced pharmaceutical service organization that is focused on quality deliverables in the areas of Clinical Programming, Biostatistics, Medical /Regulatory Writing and Comprehensive Pharmacovigilance. Commitment to Quality deliverables with robust submission experience sets MMS apart from traditional service providers. MMS Holdings Inc. is ISO-9001 certified for all services and maintains detailed quality metrics for every project. For more information visit our website at www.mmsholdings.com Article Source: http://www.biotecharticles.com/ About Author / Additional Info: Visit our blog at http://blog.mmsholdings.com Don McLean, Media Contact Email: dmclean@mmsholdings.com Phone: 734-245-0167 Comments on this article: (0 comments so far)
Additional Articles: • Bioremediation of Contaminated Soils • Biotechnology- An Excellent Hub of Career Opportunity and Advancements • Molecular Farming in Crop Plants • Types of Pseudogenes - Decoding Pseudo Notions Latest Articles in "Press Release" category: • Publish Your Biotechnology Press Releases on BiotechArticles.com • Ginger Technology (Cures for all diseases) • International Stem Cell Corporation Announces the Commercial Launch of New Skin Care Products • Greiner Bio-One in Monroe, NC Opens New Warehouse Facility • Treatment of Domestic Waste Water Using Natural Horse and Cow Dung Important Disclaimer: All articles on this website are for general information only and is not a professional or experts advice. We do not own any responsibility for correctness or authenticity of the information presented in this article, or any loss or injury resulting from it. We do not endorse these articles, we are neither affiliated with the authors of these articles nor responsible for their content. Please see our disclaimer section for complete terms. 
Copyright © 2010 biotecharticles.com - Do not copy articles from this website. |
|||||||
| | Home | Disclaimer | Xhtml | | |||||||
